A new blended genome and exome sequencing method is being reported, which may offer an unbiased and cost-effective way to capture genetic variation. This approach is being applied to various studies, including research on mental illness and hereditary cancer testing, with some outlets suggesting it can slash costs without compromising quality. The method's potential applications also extend to other areas, such as identifying genetic disorders and understanding cardiometabolic risk mechanisms.